You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
荃銀高科(300087.SZ):擬向銀行申請綜合授信額度及併購貸款
格隆匯 01-17 17:41

格隆匯 1 月 17日丨荃銀高科(300087.SZ)公佈,公司第四屆董事會第二十四次會議決議,審議通過《關於向銀行申請綜合授信額度及併購貸款的議案》;

為滿足公司生產經營活動的需要,保證生產經營活動中的流動資金需求,公司擬向中國農業發展銀行申請綜合授信額度不超過6億元。授信採用信用方式,期限為一年,授信期限內,授信額度可循環使用。最終授信額度、授信品種及授信方式等以銀行實際審批為準。

20201029日,公司第四屆董事會第二十一次會議審議通過《關於收購新疆祥豐生物科技有限公司股權的議案》,公司擬使用自有或自籌資金15512萬元收購李玉峯、姜前林合計持有的新疆祥豐生物科技有限公司(“祥豐生物”)70%股權,目前公司已使用自有資金支付股權轉讓款11323.76萬元,祥豐生物已完成股權轉讓的工商變更登記事宜,成為公司控股子公司。

現結合公司當前運營狀況及資金使用安排,公司擬向銀行申請期限不超過5年、金額不超過人民幣9300萬元的併購貸款,用於支付部分收購對價款或置換公司前期已支付的股權款。公司擬以不超過祥豐生物70%股權為本次向銀行申請併購貸款提供質押擔保,最終貸款銀行、貸款額度、貸款利率和期限以實際辦理及銀行審批為準。

議案尚需提交股東大會審議。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account